Granted
The Board granted a 60 percent rating for the Veteran's skin disability, variously diagnosed as eczema or atopic dermatitis, due to the need for constant systemic therapy such as Dupixent.
The deciding factor: The evidence supports that the Veteran has used Dupixent, which is considered systemic in nature and meets the criteria for a 60 percent evaluation under Diagnostic Code 7806.
- Claimed conditions
- eczema, atopic dermatitis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- October 23, 2025
- Citation
- A25091940
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.